Dapansutrile

Dapansutrile

SCHEMBL9935165

CS(=O)(=O)CCC#N.[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NLRP3

The experimentally established mechanism targets of Dapansutrile. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dapansutrile SCHEMBL9934796 0.97
SCHEMBL14325274 0.81
SCHEMBL31390822 0.79 NLRP3 (0.68)
Dapansutrile SCHEMBL20528619 0.79
SCHEMBL21616866 0.77 NLRP3 (0.65)
SCHEMBL18660481 0.77 NLRP3 (0.65)
SCHEMBL18660477 0.77 NLRP3 (0.65)
SCHEMBL21616867 0.77 NLRP3 (0.65)
SCHEMBL9428536 0.77
Dapansutrile SCHEMBL11291946 0.74 NLRP3 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11229620-B2 3-methanesulfonylpropionitrile for treating inflammation and/or pain OLATEC THERAPEUTICS LLC (US) 2022-01-25 US disclosed
US-20200237706-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND/OR PAIN OLATEC THERAPEUTICS, INC. 2020-07-30 US disclosed
US-20190133988-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND/OR PAIN OLATEC THERAPEUTICS, INC. 2019-05-09 US disclosed
US-10080735-B2 3-methanesulfonylpropionitrile for treating inflammation and/or pain OLATEC THERAPEUTICS LLC (US) 2018-09-25 US disclosed
US-20180125807-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND/OR PAIN OLATEC THERAPEUTICS, INC. 2018-05-10 US disclosed
US-9770428-B2 3-methanesulfonylpropionitrile for treating inflammation and pain OLATEC THERAPEUTICS LLC (US) 2017-09-26 US disclosed
US-20170119725-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC THERAPEUTICS, INC. 2017-05-04 US disclosed
EP-2651407-B1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC IND LLC (US) 2016-12-21 EP disclosed
US-9492420-B2 3-methanesulfonylpropionitrile for treating inflammation and pain OLATEC THERAPEUTICS LLC (US) 2016-11-15 US disclosed
US-20150231106-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC THERAPEUTICS, INC. 2015-08-20 US disclosed
US-8975297-B2 3-methanesulfonylpropionitrile for treating inflammation and pain OLATEC INDUSTRIES LLC (US) 2015-03-10 US disclosed
US-8829046-B2 3-methanesulfonylpropionitrile for treating inflammation and pain OLATEC INDUSTRIES LLC (US) 2014-09-09 US disclosed
US-20140228433-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC INDUSTRIES LLC (US) 2014-08-14 US disclosed
EP-2651407-A2 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN Olatec Industries LLC (US) 2013-10-23 EP disclosed
US-20130172410-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC INDUSTRIES LLC (US) 2013-07-04 US disclosed
US-8476316-B2 3-methanesulfonylpropionitrile for treating inflammation and pain OLATEC INDUSTRIES LLC (US) 2013-07-02 US disclosed
US-20120157524-A1 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC THERAPEUTICS, INC. 2012-06-21 US disclosed
WO-2012082718-A2 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN OLATEC INDUSTRIES LLC (US) 2012-06-21 WO disclosed